Reduce the use of beta cell CD20 CD37 - and promise special points

摘要

The method provided by the present invention reduces the general B cell commitment on a person using a specific molecule CD37. Specifically, the present invention provides a method for reducing the binding of specific B cell molecules to CD37 and C using CD37 monoparental or promised specific molecules. D20 - a specific commitment to a combination of synergist in some cases.This application also provides materials and methods for the treatment of diseases, including abnormal B cell activity. In addition, this application provides alpha, theta, PGE, CD37, and especially the promise of molecules.